“The Phase 1 clinical trial is designed to evaluate the safety, reactogenicity, and immunogenicity of ARCT-2304 as a potential vaccine to protect against the highly pathogenic H5N1 avian influenza.” ...
H5N1 bird flu might be more prevalent among humans than public health data shows - The number of infected dairy herds in ...
The first presumed human case of avian influenza (H5N1, or bird flu) has been reported in Canada. Canada's Health Minister ...
A B.C. teen has a suspected case of H5N1 avian flu — the first known human to acquire the virus in Canada. The provincial ...
A teenager in British Columbia, Canada has been hospitalized with a presumed case of H5N1 bird flu, the first detected human ...
Investigations are underway after a teenager from British Columbia, now receiving care in hospital, was infected via an ...
A year after an outbreak of H5N1 killed thousands of elephant seals, only about a third of the seals normally expected here ...
The CDC concluded that more bird flu testing of dairy farm employees is required. The purpose of these actions is to keep ...
The presentation, so brief as to be little more than a public service announcement, signals an abandonment of efforts to ...
In recent years, highly pathogenic avian influenza A (H5N1) virus has been sporadically detected in various mammalian hosts ...
The number of H5N1 bird flu cases in dairy cattle workers in the U.S. may be much higher than reported, indicates a new CDC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback